BACKGROUND: Axial spondyloarthritis (axSpA) is a common inflammatory arthritis of the sacroiliac joints and the spine. The best-known and most studied form of axSpA is ankylosing spondylitis. DESIGN: In this review, we provide a brief overview of the pathophysiology of axSpA. In addition, we performed a quantitative text analysis of reviews on the pathogenesis of axSpA published in the last 10 years to establish the current consensus in various fields of research into the pathogenesis of axSpA. RESULTS: There appears to be broad consensus on genetic risk factors and the involvement of the immune system in the initiation phase of the disease although little consensus was found on which specific immune cells drive disease. Moreover, despite relatively little data available, alterations in the microbiome are commonly thought to be involved in disease. Abnormal bone formation is the most prominent pathogenic factor thought to be involved in disease progression. CONCLUSION: So, although the pathophysiology of axSpA remains incompletely understood, the progress in recent years in several fields of research in axSpA including genetics, diagnosis, imaging and therapeutics, hold great promise for the future.
BACKGROUND:Axial spondyloarthritis (axSpA) is a common inflammatory arthritis of the sacroiliac joints and the spine. The best-known and most studied form of axSpA is ankylosing spondylitis. DESIGN: In this review, we provide a brief overview of the pathophysiology of axSpA. In addition, we performed a quantitative text analysis of reviews on the pathogenesis of axSpA published in the last 10 years to establish the current consensus in various fields of research into the pathogenesis of axSpA. RESULTS: There appears to be broad consensus on genetic risk factors and the involvement of the immune system in the initiation phase of the disease although little consensus was found on which specific immune cells drive disease. Moreover, despite relatively little data available, alterations in the microbiome are commonly thought to be involved in disease. Abnormal bone formation is the most prominent pathogenic factor thought to be involved in disease progression. CONCLUSION: So, although the pathophysiology of axSpA remains incompletely understood, the progress in recent years in several fields of research in axSpA including genetics, diagnosis, imaging and therapeutics, hold great promise for the future.
Authors: Michael J Nissen; Burkhard Möller; Adrian Ciurea; Ruediger B Mueller; Patrick Zueger; Martin Schulz; Fabiana Ganz; Almut Scherer; Eleftherios Papagiannoulis; Thomas Hügle Journal: Arthritis Res Ther Date: 2021-06-09 Impact factor: 5.156
Authors: Daniel B Abrar; Christoph Schleich; Styliani Tsiami; Anja Müller-Lutz; Karl Ludger Radke; Neela Holthausen; Miriam Frenken; Matthias Boschheidgen; Gerald Antoch; Johanna Mucke; Philipp Sewerin; Juergen Braun; Sven Nebelung; Xenofon Baraliakos Journal: Arthritis Res Ther Date: 2020-09-17 Impact factor: 5.156
Authors: Elvis Hysa; Carlo Alberto Cutolo; Emanuele Gotelli; Greta Pacini; Carlotta Schenone; Elke O Kreps; Vanessa Smith; Maurizio Cutolo Journal: Eur J Clin Invest Date: 2021-05-05 Impact factor: 4.686
Authors: Anne Boel; Clementina López-Medina; Désirée M F M van der Heijde; Floris Alexander van Gaalen Journal: Rheumatology (Oxford) Date: 2022-04-11 Impact factor: 7.580